Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine

Samantha M. Y. Chen,Yik Chun Wong,Lok Yan Yim,Haoji Zhang,Hui Wang,Grace Chung Yan Lui,Xin Li,Xian Tang,Lin Cheng,Yanhua Du,Qiaoli Peng,Jinlin Wang,Hau-yee Kwok,Haode Huang,Thomas Tsz-Kan Lau,Denise Pui Chung Chan,Bonnie Chun Kwan Wong,Li Liu,Lisa A. Chakrabarti,Shui Shan Lee,Zhiwei Chen
DOI: https://doi.org/10.1128/jvi.02161-21
IF: 6.549
2022-04-13
Journal of Virology
Abstract:This study presents that ICVAX, a PD1-based DNA vaccine against HIV-1, could induce broad and polyfunctional T cell responses against different HIV-1 subtypes. ICVAX encodes a recombinant antigen consisting of the human soluble PD1 domain fused with two mosaic Gag-p41 antigens.
virology
What problem does this paper attempt to address?